Brinckerhoff Quoted on Patent Trolling in Biopharma

24 July 2013 Genetic Engineering and Biotechnology News

Genetic Engineering and Biotechnology

Washington, D.C. Partner Courtenay Brinckerhoff was quoted in an article published in Genetic Engineering and Biotechnology News on July 24, 2013 titled “New Gene Patent Suit Sparks Talk of Trolls.” The article discusses a lawsuit issued by Myriad Genetics and whether or not it means patent trolling has come to biopharma. Ms. Brinckerhoff was quoted saying, “Before biotech companies decide to go into the market, they might be more cognizant or concerned about whether they have time to operate, because they’re going to invest a lot of time and money to get there.”

Related Services

Insights

Blockchain: A Tool With a Future in Healthcare
18 July 2019
Health Care Law Today
A Review of Recent Whistleblower Developments
18 July 2019
Legal News: Whistleblower Developments
Do You Know What IMMEX Stands For?
16 July 2019
Dashboard Insights
Does The U.S. Need STRONGER Patents?
16 July 2019
PTAB Trial Insights
Review of 2020 Medicare Changes for Telehealth
11 December 2019
Member Call
2019 NDI Executive Exchange
14-15 November 2019
Chicago, IL
MAGI’s Clinical Research Conference
29 October 2019
Las Vegas, NV
Association for Corporate Counsel Annual Meeting 2019
27-30 October 2019
Phoenix, AZ